Overview
Dominique Demolle is chief executive officer of Cognivia, a role she has held since January 2014. She is based in Brussels.
Before that, she was a co-founder of Aepodia SA, where she worked from February 2007 until January 2014. From 2004 to February 2007 she was associate director of global early phase operations at Eli Lilly and Company.
She obtained a Ph.D. in biochemistry from the Free University of Brussels in 1989.
Career history
In the news
- Patient behavior has often sat outside that framework, acknowledged as important but difficult to quantify. That may be starting to change. I was pleased to see #TheHealthcareTechnologyReport highlight the growing role of behavioral intelligence in clinical research. Not because it recognizes Cognivia, but because it reflects a broader evolution in how our industry is approaching some of its most persistent challenges. Retention, adherence, missed visits, treatment discontinuation. These are often discussed as operational problems.
- Clinical trials are built to reduce uncertainty. Yet one important source of uncertainty is often treated as noise rather than studied directly: #humanbehavior. When #clinicaltrial outcomes vary, our first instinct is often to look for biological explanations. 1️⃣ Did the drug work differently? 2️⃣ Was the patient population different? 3️⃣ Were there underlying disease-related factors? But what if some of that variability comes from differences in #expectations, #motivation, #adherence, or #engagement throughout the study? In a
- We are thrilled to begin collaborating with Mayo Clinic. Behavioral intelligence is a “missing layer” in better understanding patient motivation and the challenges of adhering to treatment recommendations or staying engaged in clinical studies or treatment procedures. We are honored to benefit from #MayoClinic’s insights and shared decision-making, and to collaborate on patient retention methodologies. #ClinicalResearch #BehavioralIntelligence #PatientEngagement #ClinicalTrials #SharedDecisionMaking
- Some of the most important drivers of clinical outcomes are still not considered when making decisions. Not because they don’t matter. But because we don’t make them visible early enough. Today, Cognivia announced a collaboration with Mayo Clinic to advance behavioral intelligence across clinical research and clinical care. The initial focus is pragmatic: non-adherence, missed appointments, clinical trial retention. But what matters to me is not only the scope. It is what this milestone reflects. For decades, our industry has made
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.